State of the Art Management of Patients With Neuromyelitis Optica
Released On
October 25, 2023
Expires On
October 25, 2024
Media Type
Internet
Completion Time
45 minutes
Specialty
Hematology-Oncology, Neurology
Topic(s)
Multiple Sclerosis
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This educational activity is supported by an educational grant from Genentech, a member of the Roche Group.
Credit Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity was developed for neurologists and MS specialists as well as advanced practice providers who specialize in neurology are the primary audience for this activity.
Program Overview
Join Dr. Michael Levy, neuroimmunologist at Massachusetts General Hospital, for a concise yet comprehensive 45-minute educational session on Neuromyelitis Optica Spectrum Disorder (NMOSD). This antibody-mediated autoimmune condition primarily affects the optic nerve and spinal cord, potentially leading to permanent disability. Dr. Levy's presentation is divided into four informative modules, covering NMOSD pathogenesis, diagnosis criteria, laboratory testing, imaging, and common misdiagnoses. Additionally, he discusses the safety and efficacy of approved and off-label therapy options, offering valuable insights for tailoring treatment plans to suit the unique needs of NMOSD patients.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe to a peer how AQP4-IgG testing should be applied for the diagnosis of neuromyelitis optica (NMO)
- Interpret AQP4-IgG test results when evaluating a patient who is exhibiting a neurologic syndrome consistent with NMO
- Summarize to a peer the evidence for the clinical application of approved and off-label treatments for NMO
Faculty
Michael Levy, MD, PhD
Associate Professor
Department of Neurology
Massachusetts General Hospital and Harvard Medical School
Cambridge, Massachusetts
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
The Annenberg Center designates this enduring material for a maximum 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
- Michael Levy, MD, PhD
- Advisory Board: Alexion, Genentech, Horizon, Mitsubishi, Sanofi, UCB
Additional content planners
The following have no significant relationship to disclose:
Jennifer Champagne, PharmD (Medical Writer)
Eugene Cullen, MD (Peer Reviewer)
The following have no relevant financial relationship to disclose:
Sunali Wadehra, MD Medical Writer
Kam Newman, MD (Peer Reviewer)
Amber Lea Lambert, MSN, FNP-C, DNP (Nurse Planner)
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].